Studio City, CA, United States of America

Christophe Filippi

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophe Filippi. Retrieved from https://idiyas.com/inventor/christophe-filippi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Christophe Filippi in Cancer Treatment

Introduction

Christophe Filippi is an accomplished inventor based in Studio City, CA, with a focus on groundbreaking advancements in cancer treatment. He holds three patents that showcase his innovative contributions to the field of immunotherapy.

Latest Patents

His latest patents include "Antibody-IL2 engrafted proteins and methods of use in the treatment of cancer." This patent describes IL2 engrafted into the CDR sequences of an antibody, which demonstrates preferred therapeutic profiles compared to existing clinical molecules. The compositions provided in this patent are designed to increase or maintain CD8+ T effector cells while reducing the activity of Treg cells. Additionally, these compositions offer improved half-life, stability, and producibility over recombinant human IL2 formulations such as Proleukin®. Another significant patent is "Antibody-cytokine engrafted proteins and methods of use for immune-related disorders." This invention provides antibody cytokine engrafted proteins that bind to and stimulate intracellular signaling through a high-affinity interleukin receptor. These proteins are intended to enhance anti-inflammatory cell responses and reduce pro-inflammatory effects in the treatment and prevention of immune-related disorders, including Type 1 Diabetes.

Career Highlights

Christophe Filippi is currently associated with Novartis AG, where he continues to push the boundaries of medical science through his innovative research and development efforts. His work has the potential to significantly impact the treatment landscape for various diseases.

Collaborations

He collaborates with talented professionals in his field, including Yaiza Diaz-De-Durana and Michael DiDonato, to further enhance the effectiveness of his inventions.

Conclusion

Christophe Filippi's contributions to the field of cancer treatment through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health challenges but also paves the way for future breakthroughs in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…